Transmembrane inhibitors of P-glycoprotein, an ABC transporter

Journal of Medicinal Chemistry

Volumn 48, Issue 11, 2005, Pages 3768-3775

  Tarasova, Nadya I ^a   Seth, Rishi ^a   Tarasov, Sergey G ^a   Kosakowska Cholody, Teresa ^a   Hrycyna, Christine A ^b,c   Gottesman, Michael M ^b   Michejda, Christopher J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 ETHYL 2 [3 [3 ETHYL 2(3H) BENZOXAZOLYLIDENE] 1 PROPENYL]BENZOXAZOLIUM IODIDE; ABC TRANSPORTER; BENZOXAZOLE DERIVATIVE; CYCLOSPORIN A; DOXORUBICIN; FLUORESCENT DYE; GLYCOPROTEIN P; GLYCOPROTEIN P INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CHEMOTHERAPY; CHIRALITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG SELECTIVITY; DRUG SENSITIVITY; DRUG SYNTHESIS; DRUG TARGETING; DRUG TRANSPORT; EMBRYO; FLUORESCENCE; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MOUSE; NONHUMAN; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN STRUCTURE; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLUORESCENCE; HUMANS; MICE; MOLECULAR SEQUENCE DATA; NIH 3T3 CELLS; P-GLYCOPROTEIN; PEPTIDES; PROTEIN STRUCTURE, SECONDARY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 20144370345     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm049065t     Document Type: Article

References (36)

1. Stein, W. D.; Bates, S. E.; Fojo, T. Intractable cancers: the many faces of multidrug resistance and the many targets it presents for therapeutic attack. Curr. Drag Targets 2004, 5, 333-346.
2. Leonard, G. D.; Fojo, T.; Bates, S. E. The role of ABC transporters in clinical practice. Oncologist 2003, 8, 411-424.
3. Lee, C. H. Reversing agents for ATP-binding cassette (ABC) transporters: application in modulating multidrug resistance (MDR). Curr. Med. Chem.: Anti-Cancer Agents 2004, 4, 43-52.
4. Loo, T. W.; Bartlett, M. C.; Clarke, D. M. Substrate-induced conformational changes in the transmembrane segments of human P-glycoprotein. Direct evidence for the substrate-induced fit mechanism for drug binding. J. Biol. Chem. 2003, 278, 13603-13606.
5. Rosenberg, M. F.; Kamis, A. B.; Callaghan, R.; Higgins, C. F.; Ford, R. C. Three-dimensional structures of the mammalian multidrug resistance P-glycoprotein demonstrate major conformational changes in the transmembrane domains upon nucleotide binding. J. Biol. Chem. 2003, 278, 8294-8299.
6. Chang, G.; Roth, C. B. Structure of MsbA from E. coli: a homolog of the multidrug resistance ATP binding cassette (ABC) transporters. Science 2001, 293, 1793-1800.
7. Locher, K. P.; Lee, A. T.; Rees, D. C. The E. coli: BtuCD structure: a framework for ABC transporter architecture and mechanism. Science 2002, 296, 1091-1098.
8. Tarasova, N. I.; Rice, W. G.; Michejda, C. J. Inhibition of G-protein-coupled receptor function by disruption of transmembrane domain interactions. J. Biol. Chem. 1999, 274, 34911-34915.
9. Ambudkar, S. V.; Kimchi-Sarfaty, C.; Sauna, Z. E.; Gottesman, M. M. P-glycoprotein: from genomics to mechanism. Oncogene 2003, 22, 7468-7485.
10. Neyfakh, A. A. Use of fluorescent dyes as molecular probes for the study of multidrug resistance. Exp. Cell Res. 1988, 174, 168-176.
11. Eytan, G. D.; Regev, R.; Oren, G.; Hurwitz, C. D.; Assaraf, Y. G. Efficiency of P-glycoprotein-mediated exclusion of rhodamine dyes from multidrug-resistant cells is determined by their passive transmembrane movement rate. Eur. J. Biochem. 1997, 248, 104-112.
12. Broxterman, H. J.; Schuurhuis, G. J.; Lankelma, J.; Oberink, J. W.; Eekman, C. A.; Claessen, A. M.; Hoekman, K.; Poot, M.; Pinedo, H. M. Highly sensitive and specific detection of P-glycoprotein function for haematological and solid tumour cells using a novel nucleic acid stain. Br. J. Cancer 1997, 76, 1029-1034.
13. Wadkins, R. M.; Houghton, P. J. Kinetics of transport of dialkyloxacarbocyanines in multidrug-resistant cell lines overexpressing P-glycoprotein: interrelationship of dye alkyl chain length, cellular flux, and drug resistance. Biochemistry 1995, 34, 3858-3872.
14. Tusnady, G. E.; Simon, I. The HMMTOP transmembrane topology prediction server. Bioinformatics 2001, 17, 849-850.
15. Claros, M. G.; von Heijne, G. TopPred II: an improved software for membrane protein structure predictions. Comput. Appl. Biosci. 1994, 10, 685-686.
16. Mitaku, S.; Hirokawa, T.; Tsuji, T. Amphiphilicity index of polar amino acids as an aid in the characterization of amino acid preference at membrane-water interfaces. Bioinformatics 2002, 18, 608-616.
17. Krogh, A.; Larsson, B.; von Heijne, G.; Sonnhammer, E. L. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J. Mol. Biol. 2001, 305, 567-580.
18. Kast, C.; Canfield, V.; Levenson, R.; Gros, P. Transmembrane organization of mouse P-glycoprotein determined by epitope insertion and immunofluorescence. J. Biol. Chem. 1996, 271, 9240-9248.
19. Tarasova, N. I. Receptor antagonists targeting transmembrane domains. Emerging Drugs 2000, 5, 221-229.
20. Lemmon, M. A.; Treutlein, H. R.; Adams, P. D.; Brunger, A. T.; Engelman, D. M. A dimerization motif for transmembrane alpha-helices. Nat. Struct. Biol. 1994, 1, 157-163.
21. Melnyk, R. A.; Partridge, A. W.; Deber, C. M. Transmembrane domain mediated self-assembly of major coat protein subunits from Ff bacteriophage. J. Mol. Biol. 2002, 315, 63-72.
22. Lear, J. D.; Gratkowski, H.; Adamian, L.; Liang, J.; DeGrado, W. F. Position-dependence of stabilizing polar interactions of asparagine in transmembrane helical bundles. Biochemistry 2003, 42, 6400-6407.
23. Partridge, A. W.; Melnyk, R. A.; Deber, C. M. Polar residues in membrane domains of proteins: molecular basis for helix-helix association in a mutant CFTR transmembrane segment. Biochemistry 2002, 41, 3647-3653.
24. Curran, A. R.; Engelman, D. M. Sequence motifs, polar interactions and conformational changes in helical membrane proteins. Curr. Opin. Struct. Biol. 2003, 13, 412-417.
25. Dawson, J. P.; Melnyk, R. A.; Deber, C. M.; Engelman, D. M. Sequence context strongly modulates association of polar residues in transmembrane helices. J. Mol. Biol. 2003, 331, 255-262.
26. Alvarez, M.; Paull, K; Monks, A.; Hose, C.; Lee, J. S.; Weinstein, J.; Grever, M.; Bates, S.; Fojo, T. Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen. J. Clin. Invest. 1995, 95, 2205-2214.
27. Dantzig, A. H.; Shepard, R. L.; Law, K. L.; Tabas, L.; Pratt, S.; Gillespie, J. S.; Binkley, S. N.; Kuhfeld, M. T.; Starling, J. J.; Wrighton, S. A. Selectivity of the multidrug resistance modulator, LY335979, for P-glycoprotein and effect on cytochrome P-450 activities. J. Pharmacol. Exp. Ther. 1999, 290, 854-862.
28. Mistry, P.; Stewart, A. J.; Dangerfield, W.; Okiji, S.; Liddle, C.; Bootle, D.; Plumb, J. A.; Templeton, D.; Charlton, P. In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576. Cancer Res. 2001, 61, 749-758.
29. Hebert, T. E.; Moffett, S.; Morello, J. P.; Loisel, T. P.; Bichet, D. G.; Barret, C.; Bouvier, M. A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J. Biol. Chem. 1996, 271, 16384-16392.
30. George, S. R.; Lee, S. P.; Varghese, G; Zeman, P. R.; Seeman, P.; Ng, G. Y.; O'Dowd, B. F. A transmembrane domain-derived peptide inhibits D1 dopamine receptor function without affecting receptor oligomerization. J. Biol. Chem. 1998, 273, 30244-30248.
31. George, S. R.; Ng, G. Y.; Lee, S. P.; Fan, T.; Varghese, G.; Wang, C.; Deber, C. M.; Seeman, P.; O'Dowd, B. F. Blockade of G protein-coupled receptors and the dopamine transporter by a transmembrane domain peptide: novel strategy for functional inhibition of membrane proteins in vivo. J. Pharmacol. Exp. Ther. 2003, 307, 481-489.
32. Partridge, A. W.; Melnyk, R. A.; Yang, D.; Bowie, J. U.; Deber, C. M. A transmembrane segment mimic derived from Escherichia coll diacylglycerol kinase inhibits protein activity. J. Biol. Chem. 2003, 278, 22056-22060.
33. Collins, K. D. Sticky ions in biological systems. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 5553-5557.
34. Sharom, F. J.; Lu, P.; Liu, R.; Yu, X. Linear and cyclic peptides as substrates and modulators of P-glycoprotein: peptide binding and effects on drug transport and accumulation. Biochem. J. 1998, 333 (Part 3), 621-630.
35. Hrycyna, C. A.; Airan, L. E.; Germann, U. A.; Ambudkar, S. V.; Pastan, I.; Gottesman, M. M. Structural flexibility of the linker region of human P-glycoprotein permits ATP hydrolysis and drug transport. Biochemistry 1998, 37, 13660-13673.
36. Gottesman, M. M.; Cardarelli, C.; Goldenberg, S.; Licht, T.; Pastan, I. Selection and maintenance of multidrug-resistant cells. Methods Enzymol. 1998, 292, 248-258.